Silver Point Capital L.P. Lensar, Inc. Transaction History

Silver Point Capital L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.7 - $5.9 $964,356 - $2.11 Million	-357,169 Reduced 42.62%	480,845 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$4.94 - $7.0 $558,872 - $791,924	-113,132 Reduced 11.89%	838,014 $4.65 Million
Q2 2022 Aug 15, 2022	SELL	$6.15 - $7.94 $628,794 - $811,809	-102,243 Reduced 9.71%	951,146 $6.19 Million
Q4 2020 Feb 16, 2021	BUY	$6.7 - $12.2 $7.06 Million - $12.9 Million	1,053,389 New	1,053,389 $7.64 Million

4.83M

500

49K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $48.9M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Silver Point Capital L.P., based on Form 13F filings with the SEC.

Stay updated on Silver Point Capital L.P. with notifications on news.